Iron sucrose with and without recombinant erythropoietin for the treatment of severe postpartum anemia: A prospective, randomized, open-label study

Journal of Obstetrics and Gynaecology Research

Volumn 37, Issue 2, 2011, Pages 119-124

  Krafft, Alexander ^a   Breymann, Christian ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Anemia; Iron deficiency; Iron sucrose; Postpartum; Recombinant human erythropoietin

Indexed keywords

FERRIC HYDROXIDE SUCROSE; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; ARTICLE; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FERRITIN BLOOD LEVEL; FLUSHING; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; HYPOTENSION; MONOTHERAPY; POSTPARTUM ANEMIA; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TASTE DISORDER; THROMBOEMBOLISM; TREATMENT RESPONSE;

ANEMIA; ANEMIA, IRON-DEFICIENCY; C-REACTIVE PROTEIN; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; ERYTHROCYTE INDICES; ERYTHROPOIETIN, RECOMBINANT; FEMALE; FERRIC COMPOUNDS; HEMATINICS; HUMANS; INJECTIONS, INTRAVENOUS; INTERLEUKIN-6; PREGNANCY; PREGNANCY COMPLICATIONS; PROSPECTIVE STUDIES; RANDOM ALLOCATION; TREATMENT OUTCOME;

EID: 79955953548     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2010.01328.x     Document Type: Article

References (29)

1. Dunne JR, Malone D, Tracy JK et al. Perioperative anemia: an independent risk factor for infection, mortality, and resource utilization in surgery. J Surg Res 2002; 102: 237-244. (Pubitemid 34969473)
2. Dowdle W. CDC Criteria for anemia in children and childbearing-aged women. Morb Mortal Wkly Rep 1989; 38: 400-404.
3. Huch R, Huch A. Erythropoietin in obstetrics. Hematol Oncol Clin North Am 1994; 8: 1021-1040. (Pubitemid 24314340)
4. Lefevre P, Poullin P. Current information on risks of allogenic blood transfusion TAB - The NATA Textbook. 2000; 60-66.
5. Williamson L, Lowe S, Lowe E et al. Serious hazards of transfusion (SHOT) initiative: analysis of the first two annual reports. Br Med J 1999; 319: 16-19. (Pubitemid 29304338)
6. Bhandal N, Russell R. Intravenous versus oral iron therapy for postpartum anaemia. Bjog 2006; 113: 1248-1252. (Pubitemid 44581513)
7. Van Wyck DB, Martens MG, Seid MH et al. Intravenous ferric carboxymaltose compared with oral iron in the treatment of postpartum anemia: a randomized controlled trial. Obstet Gynecol 2007; 110: 267-278. (Pubitemid 47356650)
8. Westad S, Backe B, Salvesen KA et al. A 12-week randomised study comparing intravenous iron sucrose versus oral ferrous sulphate for treatment of postpartum anemia. Acta Obstet Gynecol Scand 2008; 87: 916-923.
9. Rohling R, Zimmermann A, Breymann C. Intravenous versus oral iron supplementation for preoperative stimulation of hemoglobin synthesis using recombinant human erythropoietin. J Hematother Stem Cell Res 2000; 9: 497-500.
10. Rizzo JD, Somerfield MR, Hagerty KL et al. Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update. J Clin Oncol 2008; 26: 132-149.
11. Alghamdi AA, Albanna MJ, Guru V, Brister SJ. Does the use of erythropoietin reduce the risk of exposure to allogeneic blood transfusion in cardiac surgery? A systematic review and meta-analysis. J Card Surg 2006; 21: 320-326.
12. Breymann C, Visca E, Huch R, Huch A. Efficacy and safety of intravenously administered iron sucrose with and without adjuvant recombinant human erythropoietin for the treatment of resistant iron-deficiency anemia during pregnancy. Am J Obstet Gynecol 2001; 184: 662-667. (Pubitemid 32234981)
13. Hatzis T, Cardamakis E, Tsapanos V et al. The effects of recombinant human erythropoietin given immediately after delivery to women with anaemia. Curr Med Res Opin 2003; 19: 346-349. (Pubitemid 36827845)
14. Bencaiova G, Krafft A, Burkhardt T, Breymann C. Variable eficacy of recombinant human erythropoietin in anemic pregnant women with different forms of heterozygous hemoglobinopathy. Acta Haematol 2006; 116: 259-265. (Pubitemid 44795906)
15. Wagstrom E, Akesson A, Van Rooijen M et al. Erythropoietin and intravenous iron therapy in postpartum anaemia. Acta Obstet Gynecol Scand 2007; 86: 957-962. (Pubitemid 47123611)
16. Jongen-Lavrencic M, Peeters HR, Vreugdenhil G, Swaak AJ. Interaction of inflammatory cytokines and erythropoeitin in iron metabolism and erythropoiesis in anaemia of chronic disease. Clin Rheumatol 1995; 14: 519-525.
17. Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 2003; 102: 783-788. (Pubitemid 36917762)
18. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med 2005; 352: 1011-1023.
19. Breymann C, Perewusnyk G, Guntermann H et al. Unrecognised iron deiciency in critical illness. Lancet 1999; 353:841-842.
20. van Iperen CE, Kraaijenhagen RJ, Biesma DH et al.Iron metabolism and erythropoiesis after surgery. Br J Surg 1998; 85: 41-45. (Pubitemid 28034109)
21. Cazzola M, Mercuriali F, Brugnara C. Use of recombinant human erythropoietin outside the setting of uremia. Blood 1997; 89: 4248-4267. (Pubitemid 27260232)
22. Breymann C, Richter C, Hüttner C et al. Effectiveness of recombinant erythropoietin and iron sucrose vs. iron therapy only, in patients with postpartum anaemia and blunted eryth- ropoiesis. Eur J Clin Invest 2000; 30: 154-161. (Pubitemid 30079574)
23. Huch A, Eichhorn KH, Danko J et al. Recombinant human erythropoietin in the treatment of postpartum anemia. Obstet Gynecol 1992; 80: 127-131.
24. Breymann C, Zimmermann R, Huch R, Huch A. Use of recombinant human erythropoietin in combination with parenteral iron in the treatment of postpartum anaemia. Eur J Clin Invest 1996; 26: 123-130. (Pubitemid 26064615)
25. Broche DE, Gay C, Armand-Branger S et al. [Acute postpartum anaemia. Clinical practice and interest of intravenous iron]. Gynecol Obstet Fertil 2004; 32: 613-619. (Pubitemid 39178117)
26. Cazzola M, Ponchio L, de Benedetti F et al. Defective iron supply for erythropoiesis and adequate endogenous erythro- poietin production in the anemia associated with systemic- onset juvenile chronic arthritis. Blood 1996; 87: 4824-830. (Pubitemid 26162385)
27. Hoigné R, Breymann C, Künzi U, Brunner F. Parenteral iron therapy: problems and possible solutions. Schweiz Med Wochenschr 1998; 128: 528-535. (Pubitemid 28143937)
28. Singbartl G. Adverse events of erythropoietin in long-term and in acute/short-term treatment. Clin Investig 1994; 72: S36-S43. (Pubitemid 24208378)
29. McKoy JM, Stonecash RE, Cournoyer D et al. Epoetin-associated pure red cell aplasia: past, present, and future considerations. Transfusion 2008; 48: 1754-1762.